Pfs Investments Inc. Horizon Therapeutics Public LTD CO Transaction History

Pfs Investments Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$107.32 - $113.5 $1.71 Million - $1.81 Million	-15,907 Reduced 82.33%	3,414 $371,000
Q4 2022 Feb 13, 2023	SELL	$62.39 - $113.8 $26,453 - $48,251	-424 Reduced 2.15%	19,321 $2.2 Million
Q3 2022 Nov 14, 2022	SELL	$58.92 - $84.67 $3.29 Million - $4.72 Million	-55,787 Reduced 73.86%	19,745 $1.22 Million
Q2 2022 Aug 12, 2022	BUY	$79.4 - $116.36 $453,532 - $664,648	5,712 Added 8.18%	75,532 $6.02 Million
Q1 2022 May 16, 2022	BUY	$86.42 - $109.81 $818,483 - $1.04 Million	9,471 Added 15.69%	69,820 $7.35 Million
Q4 2021 Feb 11, 2022	BUY	$98.56 - $119.91 $505,612 - $615,138	5,130 Added 9.29%	60,349 $6.5 Million
Q3 2021 Nov 15, 2021	BUY	$91.91 - $110.37 $366,169 - $439,714	3,984 Added 7.78%	55,219 $5.97 Million
Q2 2021 Aug 13, 2021	BUY	$86.24 - $95.92 $217,238 - $241,622	2,519 Added 5.17%	51,235 $4.88 Million
Q1 2021 May 17, 2021	BUY	$71.83 - $95.48 $1.87 Million - $2.49 Million	26,044 Added 114.87%	48,716 $4.48 Million
Q4 2020 Feb 16, 2021	BUY	$67.0 - $84.39 $299,356 - $377,054	4,468 Added 24.54%	22,672 $1.78 Million
Q3 2020 Nov 13, 2020	BUY	$55.23 - $79.93 $1.01 Million - $1.46 Million	18,204 New	18,204 $1.41 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Pfs Investments Inc., based on Form 13F filings with the SEC.

Stay updated on Pfs Investments Inc. with notifications on news.